VERV · Insider Trading
Verve Therapeutics, Inc. Common Stock
Every open-market purchase and sale reported by VERV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-28 | Lonnel Coats | Director | D | −178,339 deriv. | — |
| 2025-07-28 | Ourania Tatsis | Director | D | −309,741 deriv. | — |
| 2025-07-28 | Allison Dorval | Chief Financial Officer | U | −13,280 | — |
| 2025-07-28 | Troy Lister | Chief Scientific Officer | U | −6,952 | — |
| 2025-07-28 | Sheila Mikhail | Director | D | −221,537 deriv. | — |
| 2025-07-28 | Joan Nickerson | Chief Administrative Officer | U | −17,420 | — |
| 2025-07-28 | Krishna Yeshwant | Director | U | −12,168,489 | — |
| 2025-07-28 | Burt A Adelman | Director | U | −428,326 | — |
| 2025-07-28 | Jodie Pope Morrison | Director | D | −309,741 deriv. | — |
| 2025-07-28 | Andrew D. Ashe | See Remarks | U | −348,828 | — |
| 2025-07-28 | Alexander Cumbo | Director | D | −178,339 deriv. | — |
| 2025-07-28 | Michael F MacLean | Director | D | −178,339 deriv. | — |
| 2025-07-28 | Sekar Kathiresan | Chief Executive Officer | U | −700,425 | — |
| 2025-07-28 | Jason Politi | Chief Technical Ops. Off. | U | −16,405 | — |
| 2025-07-28 | GV 2023 GP, L.P. | 10%+ Owner | U | −121,684,890 | — |
| 2025-06-06 | Sheila Mikhail | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Burt A Adelman | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Krishna Yeshwant | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Jodie Pope Morrison | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Lonnel Coats | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Alexander Cumbo | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Ourania Tatsis | Director | A | +42,200 deriv. | — |
| 2025-06-06 | Michael F MacLean | Director | A | +42,200 deriv. | — |
| 2025-04-03 | Joan Nickerson | Chief Administrative Officer | MIXED | +6,538 | −$11.52K |
| 2025-04-03 | Sekar Kathiresan | Chief Executive Officer | MIXED | +23,178 | −$40.76K |
| 2025-04-03 | Andrew D. Ashe | See Remarks | MIXED | +6,319 | −$11.13K |
| 2025-04-03 | Allison Dorval | Chief Financial Officer | MIXED | +7,900 | −$13.90K |
| 2025-04-03 | Jason Politi | Chief Technical Ops. Off. | MIXED | +5,580 | −$13.43K |
| 2025-04-03 | Troy Lister | Chief Scientific Officer | MIXED | +5,151 | −$9.08K |
| 2025-01-10 | Andrew D. Ashe | See Remarks | A | +265,000 deriv. | — |
| 2025-01-10 | Jason Politi | Chief Technical Ops. Off. | A | +265,000 deriv. | — |
| 2025-01-10 | Joan Nickerson | Chief Administrative Officer | A | +265,000 deriv. | — |
| 2025-01-10 | Allison Dorval | Chief Financial Officer | A | +378,000 deriv. | — |
| 2025-01-10 | Troy Lister | Chief Scientific Officer | A | +265,000 deriv. | — |
| 2025-01-10 | Sekar Kathiresan | Chief Executive Officer | A | +758,000 deriv. | — |
| 2024-12-04 | Sekar Kathiresan | Chief Executive Officer | G | — | — |
| 2024-12-03 | Allison Dorval | Chief Financial Officer | MIXED | +1,320 | −$3.13K |
| 2024-07-02 | Sekar Kathiresan | Chief Executive Officer | M | +30,000 | +$86.10K |
| 2024-06-28 | Lonnel Coats | Director | A | +136,139 deriv. | — |
| 2024-06-28 | Michael F MacLean | Director | A | +136,139 deriv. | — |
| 2024-06-28 | Burt A Adelman | Director | A | +136,139 deriv. | — |
| 2024-06-28 | Krishna Yeshwant | Director | A | +136,139 deriv. | — |
| 2024-06-28 | Alexander Cumbo | Director | A | +136,139 deriv. | — |
| 2024-06-28 | Jodie Pope Morrison | Director | A | +267,541 deriv. | — |
| 2024-06-28 | Sheila Mikhail | Director | A | +136,139 deriv. | — |
| 2024-06-28 | Ourania Tatsis | Director | A | +267,541 deriv. | — |
| 2024-06-25 | Troy Lister | Chief Scientific Officer | A | +32,000 deriv. | — |
| 2024-05-15 | Andrew D. Ashe | See Remarks | Buy | +76,000 | +$475.76K |
| 2024-04-03 | Joan Nickerson | Chief Administrative Officer | MIXED | +1,801 | −$12.48K |
| 2024-02-16 | Sekar Kathiresan | Chief Executive Officer | A | +658,000 deriv. | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VERV quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.